---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-23-000147"
form_type: "8-K"
ticker: "CMMB"
cik: "0001534248"
company_name: "Chemomab Therapeutics Ltd."
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:32:29.870320+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Chemomab Therapeutics furnishes updated corporate presentation; no specific facts available from filing text

## Summary
- Chemomab Therapeutics filed an updated corporate presentation on January 11, 2023.
- The presentation is intended for investor and analyst use; no financial results or material events were announced.
- No further details from the presentation are included in the filing text provided.

## SEC filing metadata
- accession: 0001178913-23-000147
- form_type: 8-K
- ticker: CMMB
- cik: 0001534248
- company_name: Chemomab Therapeutics Ltd.
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534248/000117891323000147/0001178913-23-000147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534248/000117891323000147/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-23-000147
- JSON: https://secwatch.observer/filing/0001178913-23-000147.json
- Plain text: https://secwatch.observer/filing/0001178913-23-000147.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.